Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3681519012 | Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
3681520018 | Acetaminophen 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | en | Synonym | Active | Case insensitive | SNOMED CT core |
3681521019 | Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | en | Synonym | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Is a | Paracetamol and phenyltoloxamine and salicylamide only product in oral dose form | true | Inferred relationship | Some | ||
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Has BoSS | Salicylamide | true | Inferred relationship | Some | 2 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Has BoSS | Phenyltoloxamine citrate | true | Inferred relationship | Some | 1 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Has precise active ingredient | Paracetamol | true | Inferred relationship | Some | 3 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Has precise active ingredient | Salicylamide | true | Inferred relationship | Some | 2 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Has BoSS | Paracetamol | true | Inferred relationship | Some | 3 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Has precise active ingredient | Phenyltoloxamine citrate | true | Inferred relationship | Some | 1 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Is a | Phenyltoloxamine-containing product | false | Inferred relationship | Some | ||
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Is a | Paracetamol compound preparation | false | Inferred relationship | Some | ||
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Has active ingredient | Ethanolamine | false | Inferred relationship | Some | ||
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Has active ingredient | Sedating antihistamine | false | Inferred relationship | Some | ||
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Has active ingredient | Non-opioid analgesic | false | Inferred relationship | Some | ||
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Has active ingredient | Phenyltoloxamine | false | Inferred relationship | Some | ||
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Is a | Paracetamol + phenyltoloxamine citrate + salicylamide | false | Inferred relationship | Some | ||
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Has active ingredient | Phenyltoloxamine citrate | false | Inferred relationship | Some | ||
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Has active ingredient | Salicylamide | false | Inferred relationship | Some | ||
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Has active ingredient | Paracetamol | false | Inferred relationship | Some | ||
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Has manufactured dose form | Capsule | false | Inferred relationship | Some | ||
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Has active ingredient | Cardiovascular agent | false | Inferred relationship | Some | ||
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Has manufactured dose form | Conventional release oral capsule | true | Inferred relationship | Some | ||
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Is a | Paracetamol-containing product in oral dose form | false | Inferred relationship | Some | ||
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Has active ingredient | Paracetamol | false | Inferred relationship | Some | 1 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Has BoSS | Paracetamol | false | Inferred relationship | Some | 1 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Has presentation strength numerator value | 300 | false | Inferred relationship | Some | 1 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Has presentation strength denominator unit | Capsule | true | Inferred relationship | Some | 1 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 2 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Has presentation strength denominator unit | Capsule | true | Inferred relationship | Some | 2 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 3 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 3 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Has presentation strength denominator unit | Capsule | true | Inferred relationship | Some | 3 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Has active ingredient | Phenyltoloxamine citrate | false | Inferred relationship | Some | 2 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Has BoSS | Phenyltoloxamine citrate | false | Inferred relationship | Some | 2 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Has presentation strength numerator value | 20 | false | Inferred relationship | Some | 2 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Has active ingredient | Salicylamide | false | Inferred relationship | Some | 3 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Has BoSS | Salicylamide | false | Inferred relationship | Some | 3 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Has presentation strength numerator value | 200 | false | Inferred relationship | Some | 3 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Has active ingredient | Phenyltoloxamine citrate | false | Inferred relationship | Some | ||
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Has active ingredient | Salicylamide | false | Inferred relationship | Some | ||
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Has active ingredient | Paracetamol | false | Inferred relationship | Some | ||
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Has precise active ingredient | Salicylamide | false | Inferred relationship | Some | 3 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Has unit of presentation | Capsule | true | Inferred relationship | Some | ||
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Has precise active ingredient | Phenyltoloxamine citrate | false | Inferred relationship | Some | 2 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Has precise active ingredient | Paracetamol | false | Inferred relationship | Some | 1 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Is a | Paracetamol- and phenyltoloxamine- and salicylamide-containing product in oral dose form | false | Inferred relationship | Some | ||
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | Count of base of active ingredient | 3 | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets